Literature DB >> 10485708

Rapid on/off cycling of cytokine production by virus-specific CD8+ T cells.

M K Slifka1, F Rodriguez, J L Whitton.   

Abstract

CD8-positive T cells protect the body against viral pathogens by two important mechanisms: production of antiviral cytokines and lysis of infected cells. Cytokine production can have both local and systemic consequences, whereas cytolytic activity is limited to infected cells that are in direct contact with T cells. Here we analyse activated CD8-positive T cells from mice infected with lymphocytic choriomeningitis virus and find that cytokines are not produced ex vivo in the absence of peptide stimulation, but that they are rapidly generated after T cells encounter viral peptides bound to the major histocompatibility complex. Remarkably, cytokine production ceases immediately upon dissociation of the T cells from their targets and resumes when antigenic contact is restored. In contrast to the 'on/off/on' cycling of cytokines, the pore-forming cytotoxic protein perforin is constitutively maintained. Our results indicate that there is differential expression of effector molecules according to whether the antiviral product is secreted (like cytokines) or stored inside the cell (like perforin). The ability to turn cytokines on and off while maintaining intracellular stores of perforin shows the versatility of the cellular immune response and provides a mechanism for maintaining effective immune surveillance while reducing systemic immunopathology.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10485708     DOI: 10.1038/43454

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  80 in total

1.  Gamma interferon expression in CD8(+) T cells is a marker for circulating cytotoxic T lymphocytes that recognize an HLA A2-restricted epitope of human cytomegalovirus phosphoprotein pp65.

Authors:  S A Ghanekar; L E Nomura; M A Suni; L J Picker; H T Maecker; V C Maino
Journal:  Clin Diagn Lab Immunol       Date:  2001-05

2.  Immune responses following neonatal DNA vaccination are long-lived, abundant, and qualitatively similar to those induced by conventional immunization.

Authors:  D E Hassett; J Zhang; M Slifka; J L Whitton
Journal:  J Virol       Date:  2000-03       Impact factor: 5.103

Review 3.  Immunofluorescence analysis of T-cell responses in health and disease.

Authors:  H T Maecker; V C Maino; L J Picker
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

Review 4.  Detection and analysis of antigen-specific CD8+ T cells.

Authors:  V P Badovinac; J T Harty
Journal:  Immunol Res       Date:  2001       Impact factor: 2.829

Review 5.  Plasticity in programming of effector and memory CD8 T-cell formation.

Authors:  Ramon Arens; Stephen P Schoenberger
Journal:  Immunol Rev       Date:  2010-05       Impact factor: 12.988

6.  Rapid recruitment of virus-specific CD8 T cells restructures immunodominance during protective secondary responses.

Authors:  Anne E Tebo; Michael J Fuller; Dalia E Gaddis; Kyoko Kojima; Kunal Rehani; Allan J Zajac
Journal:  J Virol       Date:  2005-10       Impact factor: 5.103

7.  Immunization with non-replicating E. coli minicells delivering both protein antigen and DNA protects mice from lethal challenge with lymphocytic choriomeningitis virus.

Authors:  Matthew J Giacalone; Juan C Zapata; Neil L Berkley; Roger A Sabbadini; Yen-Lin Chu; Maria S Salvato; Kathleen L McGuire
Journal:  Vaccine       Date:  2006-12-26       Impact factor: 3.641

8.  Optimization of the cytokine secretion assay for human IL-2 in single and combination assays.

Authors:  Nan Deng; Tim R Mosmann
Journal:  Cytometry A       Date:  2015-04-28       Impact factor: 4.355

Review 9.  Intravital imaging of CD8+ T cell function in cancer.

Authors:  Thorsten R Mempel; Christian A Bauer
Journal:  Clin Exp Metastasis       Date:  2008-07-30       Impact factor: 5.150

10.  Granzyme B production distinguishes recently activated CD8(+) memory cells from resting memory cells.

Authors:  Tobias M Nowacki; Stefanie Kuerten; Wenji Zhang; Carey L Shive; Christian R Kreher; Bernhard O Boehm; Paul V Lehmann; Magdalena Tary-Lehmann
Journal:  Cell Immunol       Date:  2007-09-07       Impact factor: 4.868

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.